{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:45:32Z","timestamp":1761129932740},"reference-count":13,"publisher":"Jaypee Brothers Medical Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,8]]},"DOI":"10.5005\/jp-journals-10071-23938","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T11:16:12Z","timestamp":1630408572000},"page":"1079-1080","source":"Crossref","is-referenced-by-count":7,"title":["Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?"],"prefix":"10.5005","volume":"25","author":[{"given":"Sayan","family":"Nath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"ref=1","unstructured":"1. Available at https:\/\/www.covid19india.org\/ (accessed 23 May 2021)."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diab Metabol Syndr Clin Res Rev. 2021. DOI: 10.1016\/j.dsx.2021.05.019.","DOI":"10.1016\/j.dsx.2021.05.019"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms 2021;9:523. DOI: 10.3390\/microorganisms9030523.","DOI":"10.3390\/microorganisms9030523"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Gangneux JP, Bougnoux ME, Dannaoui E. Invasive fungal diseases during COVID-19: We should be prepared. J Mycol Med 2020;30(2):100971. DOI: 10.1016\/j.mycmed.2020.100971.","DOI":"10.1016\/j.mycmed.2020.100971"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Thomas S, Patel D, Bittel B. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA Netw Open 2021;4(2):e210369. DOI: 10.1001\/jamanetworkopen.2021.0369.","DOI":"10.1001\/jamanetworkopen.2021.0369"},{"key":"ref=6","unstructured":"6. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Available at: https:\/\/www.covid19treatmentguidelines.nih.gov\/ (accessed 23 May 2021)."},{"key":"ref=7","unstructured":"7. Management protocol for COVID-19. Available at: http:\/\/www.wbhealth.gov.in (accessed 23 May 2021)."},{"key":"ref=8","unstructured":"8. Revised guideline for home isolation\/home care of COVID-19 positive patients. Municipal Corporation of Greater Mumbai. Available at: https:\/\/www.mumbai.in.emb-japan.go.jp\/files\/100170201.pdf (accessed 23 May 2021)."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Wilson D. An evolutionary perspective on zinc uptake by human fungal pathogens. Metallomics 2015;7(6):979\u2013985. DOI: 10.1039\/c4mt00331d.","DOI":"10.1039\/C4MT00331D"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Staats CC, Kmetzsch L, Schrank A, Vainstein MH. Fungal zinc metabolism and its connections to virulence. Front Cell Infect Microbiol 2013;3:65. DOI: 10.3389\/fcimb.2013.00065.","DOI":"10.3389\/fcimb.2013.00065"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Lulloff SJ, Hahn BL, Sohnle PG. Fungal susceptibility to zinc deprivation. J Lab Clin Med 2004;144:208\u2013214. DOI: 10.1016\/j.lab.2004.07.007.","DOI":"10.1016\/j.lab.2004.07.007"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Leonardelli F, Macedo D, Dudiuk C, Theill L, Cabeza MS, Gamarra S, et al. In vitro activity of combinations of zinc chelators with amphotericin B and posaconazole against six mucorales species. Antimicrob Agents Chemother 2019;63(5):e00266. DOI: 10.1128\/AAC.00266-19.","DOI":"10.1128\/AAC.00266-19"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Cohrt KAO, Mar\u00edn L, Kjellerup L, Clausen JD, Dalby-Brown W, Calera JA, et al. Novel zinc-attenuating compounds as potent broad-spectrum antifungal agents with in vitro and in vivo efficacy. Antimicrob Agents Chemother 2018;62(5):e02024. DOI: 10.1128\/AAC.02024-17.","DOI":"10.1128\/AAC.02024-17"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.5005\/jp-journals-10071-23938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T16:20:34Z","timestamp":1657902034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.5005\/jp-journals-10071-23938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021]]}},"alternative-id":["10.5005\/jp-journals-10071-23938"],"URL":"https:\/\/doi.org\/10.5005\/jp-journals-10071-23938","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]}}}